New nerve block aims to slash opioid use after shoulder surgery
NCT ID NCT06143306
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a pectoserratus nerve block to the standard interscalene block can better control pain and reduce opioid use after total shoulder replacement. About 110 adults aged 18 to 85 having shoulder replacement will be randomly assigned to receive either a numbing medicine or a placebo (salt water) in the extra block. The main goal is to see if the extra block lowers the highest pain score in the first 24 hours after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL SHOULDER ARTHROPLASTY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.